Clinical practice update: management of infectious endophthalmitis after intravitreal anti-VEGF injection

Rohan Merani; Mark W. Johnson; Colin A. McCannel; Harry W. Flynn Jr; Ingrid U. Scott; Alex P. Hunyor

doi:10.1177/24741264221116487

Clinical practice update: management of infectious endophthalmitis after intravitreal anti-VEGF injection

Rohan Merani, Mark W. Johnson, Colin A. McCannel, Harry W. Flynn Jr, Ingrid U. Scott, Alex P. Hunyor^*

^*Corresponding author for this work

Macquarie Medical School

Research output: Contribution to journal › Review article › peer-review

8 Citations (Scopus)

Abstract

Although infectious endophthalmitis after intravitreal antivascular endothelial growth factor injections is rare, it is the most feared and potentially devastating complication of this procedure. There is no high-level evidence to provide definitive guidance on the management of endophthalmitis occurring after intravitreal injection (IVI). This clinical practice update reviews the published literature regarding post-IVI endophthalmitis and highlights areas in which further research is needed to better guide its management.

Original language	English
Pages (from-to)	443-451
Number of pages	9
Journal	Journal of Vitreoretinal Diseases
Volume	6
Issue number	6
DOIs	https://doi.org/10.1177/24741264221116487
Publication status	Published - 1 Nov 2022

Keywords

endophthalmitis
intravitreal injection
vascular endothelial growth factor

Access to Document

10.1177/24741264221116487

Cite this

@article{4d080188b92842ca940fb9f858f23e17,

title = "Clinical practice update: management of infectious endophthalmitis after intravitreal anti-VEGF injection",

abstract = "Although infectious endophthalmitis after intravitreal antivascular endothelial growth factor injections is rare, it is the most feared and potentially devastating complication of this procedure. There is no high-level evidence to provide definitive guidance on the management of endophthalmitis occurring after intravitreal injection (IVI). This clinical practice update reviews the published literature regarding post-IVI endophthalmitis and highlights areas in which further research is needed to better guide its management.",

keywords = "endophthalmitis, intravitreal injection, vascular endothelial growth factor",

author = "Rohan Merani and Johnson, {Mark W.} and McCannel, {Colin A.} and {Flynn Jr}, {Harry W.} and Scott, {Ingrid U.} and Hunyor, {Alex P.}",

year = "2022",

month = nov,

day = "1",

doi = "10.1177/24741264221116487",

language = "English",

volume = "6",

pages = "443--451",

journal = "Journal of Vitreoretinal Diseases",

issn = "2474-1264",

publisher = "SAGE Publications",

number = "6",

}

TY - JOUR

T1 - Clinical practice update

T2 - management of infectious endophthalmitis after intravitreal anti-VEGF injection

AU - Merani, Rohan

AU - Johnson, Mark W.

AU - McCannel, Colin A.

AU - Flynn Jr, Harry W.

AU - Scott, Ingrid U.

AU - Hunyor, Alex P.

PY - 2022/11/1

Y1 - 2022/11/1

N2 - Although infectious endophthalmitis after intravitreal antivascular endothelial growth factor injections is rare, it is the most feared and potentially devastating complication of this procedure. There is no high-level evidence to provide definitive guidance on the management of endophthalmitis occurring after intravitreal injection (IVI). This clinical practice update reviews the published literature regarding post-IVI endophthalmitis and highlights areas in which further research is needed to better guide its management.

AB - Although infectious endophthalmitis after intravitreal antivascular endothelial growth factor injections is rare, it is the most feared and potentially devastating complication of this procedure. There is no high-level evidence to provide definitive guidance on the management of endophthalmitis occurring after intravitreal injection (IVI). This clinical practice update reviews the published literature regarding post-IVI endophthalmitis and highlights areas in which further research is needed to better guide its management.

KW - endophthalmitis

KW - intravitreal injection

KW - vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=85155429977&partnerID=8YFLogxK

U2 - 10.1177/24741264221116487

DO - 10.1177/24741264221116487

M3 - Review article

C2 - 37009541

SN - 2474-1264

VL - 6

SP - 443

EP - 451

JO - Journal of Vitreoretinal Diseases

JF - Journal of Vitreoretinal Diseases

IS - 6

ER -

Clinical practice update: management of infectious endophthalmitis after intravitreal anti-VEGF injection

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this